Institut de Recherche en Cancérologie de Montpellier
Sommaire
Projet scientifique
Publications
Equipe

Principales publications

Charles Theillet. What do we learn from HER2-positive breast cancer genomic profiles? Breast Cancer Research 2010, 12:107 (1 June 2010)

Tuduri S, Crabbe L, Tourrière H, Coquelle A, Pasero P. Does interference between replication and transcription contribute to genomic instability in cancer cells? Cell Cycle. 2010 May 17;9(10). [Epub ahead of print]PMID: 20495385

Herfs M, Hubert P, Suarez-Carmona M, Reschner A, Saussez S, Berx G, Savagner P, Boniver J, Delvenne P. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. Am J Pathol. 2010 Apr;176(4):1941-9. Epub 2010 Feb 11.PMID: 20150431

Docquier A, Harmand PO, Fritsch S, Chanrion M, Darbon JM, Cavaillès V. The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes. Clin Cancer Res. 2010 May 18. [Epub ahead of print]PMID: 20410059

Tuduri S, Crabbé L, Conti C, Tourrière H, Holtgreve-Grez H, Jauch A, Pantesco V, De Vos J, Thomas A, Theillet C, Pommier Y, Tazi J, Coquelle A, Pasero P. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat Cell Biol. 2009 Nov;11(11):1315-24. Epub 2009 Oct 18.

Klymkowsky MW, Savagner P. Epithelial-Mesenchymal Transition. A Cancer Researcher's Conceptual Friend and Foe. Am J Pathol 2009 May;174(5):1588-93.

Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P. Erk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing. Mol Biol Cell 2008 Nov; 19: 4738-49

Chanrion, M., Fontaine, H., Rodriguez, C., Negre, V., Bibeau, F., Theillet, C., Henaut, A., and Darbon, J. M. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. BMC Cancer, 7: 39, 2007.

Moll, F., Millet, C., Noel, D., Orsetti, B., Bardin, A., Katsaros, D., Jorgensen, C., Garcia, M., Theillet, C., Pujol, P., and Francois, V. Chordin is underexpressed in ovarian tumors and reduces tumor cell motility. Faseb J, 20: 240-250, 2006.

Olivier, M., Langerod, A., Carrieri, P., Bergh, J., Klaar, S., Eyfjord, J., Theillet, C., Rodriguez, C., Lidereau, R., Bieche, I., Varley, J., Bignon, Y., Uhrhammer, N., Winqvist, R., Jukkola-Vuorinen, A., Niederacher, D., Kato, S., Ishioka, C., Hainaut, P., and Borresen-Dale, A. L. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res, 12: 1157-1167, 2006.

Orsetti, B., Nugoli, M., Cervera, N., Lasorsa, L., Chuchana, P., Rouge, C., Ursule, L., Nguyen, C., Bibeau, F., Rodriguez, C., and Theillet, C. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer, 95: 1439-1447, 2006.

Come, C., F. Magnino, et al. "Snail and Slug play distinct roles during breast carcinoma progression." Clin Cancer Res, 12 : 5395-5402, 2006.

Bardet, P. L., B. Horard, et al. "The ERRalpha orphan nuclear receptor controls morphogenetic movements during zebrafish gastrulation." Dev Biol 281(1): 102-111, 2005.

Gelsi-Boyer, V., B. Orsetti, et al. "Comprehensive profiling of 8p11-12 amplification in breast cancer." Mol Cancer Res 3(12): 655-667, 2005.

 

Institut de Recherche en Cancérologie de Montpellier - 2007 - tous droits réservés - Conception : ID Alizés